US BANCORP \DE\ - CLEVELAND BIOLABS INC ownership

Quarter-by-quarter ownership
US BANCORP \DE\ ownership history of CLEVELAND BIOLABS INC
ValueSharesWeighting
Q2 2021$5,0000.0%1,0000.0%0.00%
Q1 2021$5,0001,000
+900.0%
0.00%
Q3 2018$01000.0%0.00%
Q2 2018$01000.0%0.00%
Q1 2018$01000.0%0.00%
Q4 2017$01000.0%0.00%
Q3 2017$01000.0%0.00%
Q2 2017$01000.0%0.00%
Q1 2017$01000.0%0.00%
Q4 2016$01000.0%0.00%
Q3 2016$01000.0%0.00%
Q2 2016$01000.0%0.00%
Q1 2016$01000.0%0.00%
Q4 2015$01000.0%0.00%
Q3 2015$01000.0%0.00%
Q2 2015$01000.0%0.00%
Q1 2015$01000.00%
Other shareholders
CLEVELAND BIOLABS INC shareholders Q3 2021
NameSharesValueWeighting ↓
Renaissance Technologies 281,916$567,0000.00%
VANGUARD GROUP INC 170,347$342,0000.00%
LADENBURG THALMANN FINANCIAL SERVICES INC. 20$00.00%
UBS Group AG 2,056$4,0000.00%
Stratos Wealth Partners, LTD. 100$00.00%
IFP Advisors, Inc 150$00.00%
Advisor Group, Inc. 25$00.00%
US BANCORP \DE\ 100$00.00%
BANK OF AMERICA CORP /DE/ 253$1,0000.00%
WELLS FARGO & COMPANY/MN 200$00.00%
View complete list of CLEVELAND BIOLABS INC shareholders